Psychiatric clinical trials: addressing methodological challenges
Introduction Psychiatric clinical trials are vital to advancing the treatment and understanding of mental health disorders. This emphasizes the need for biomarkers to enhance psychiatric treatments, particularly for disorders like schizophrenia and depression, where identifying specific subtypes could lead to more targeted and effective therapies [1], but they often face serious methodological challenges that can […]
